Literature DB >> 21373921

Improved methodology to induce hyperoxaluria without treatment using hydroxyproline.

John H Wiessner1, Michael R Garrett, Linda Y Hung, David F Wille, Neil S Mandel.   

Abstract

The use of hydroxyproline (HP) to generate hyperoxaluria in the rat is a problem because it is impossible to separate the effect of oxalate on renal injury from the effects of HP and the large array of metabolic intermediates formed when HP is converted to oxalate. Previously, the Dahl salt-sensitive (SS) and Brown Norway (BN) rat strains were studied to determine genetic control of resistance or susceptibility to HP-induced renal injury and crystal deposition. To develop a better model to induce hyperoxaluria without causing injury from HP metabolites, animals were fed a diet containing various levels of added oxalate (0, 1, 2, 3, or 5%). After 5 weeks rats were killed and the kidneys were removed for microscopic evaluation of tubule changes and crystal deposition. The 3 and 5% oxalate-fed groups had a substantial increase in urine oxalate, about 50 and 140 μmol/g body weight over controls, respectively. Both the SS and BN 3% oxalate-fed animals showed only slightly elevated tubule area and no crystal deposition. However, BN animals fed 5% oxalate had a dramatic increase in their percent tubule areas compared to control BN rats and treated SS rats. Crystal deposition in the kidneys was only observed in the 5% oxalate-fed groups. The BN kidneys demonstrated a threefold higher crystal deposition compared to oxalate-fed SS rats. We conclude that oxalate-supplemented food is a better method of producing hyperoxaluria in the rat than using HP which may introduce metabolic intermediates injurious to the kidney.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21373921      PMCID: PMC3374404          DOI: 10.1007/s00240-011-0368-8

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

Review 1.  Medical management of urinary stone disease.

Authors:  Charles Y C Pak
Journal:  Nephron Clin Pract       Date:  2004

2.  Purification and properties of oxalic acid oxidase.

Authors:  J Chiriboga
Journal:  Arch Biochem Biophys       Date:  1966-09-26       Impact factor: 4.013

3.  Control of oxalate formation from L-hydroxyproline in liver mitochondria.

Authors:  Tatsuya Takayama; Kimio Fujita; Kazuo Suzuki; Michiko Sakaguchi; Michio Fujie; Erina Nagai; Shinya Watanabe; Arata Ichiyama; Yoshihide Ogawa
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

4.  Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

Authors:  J Knight; J Jiang; D G Assimos; R P Holmes
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

Review 5.  Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Authors:  A Evan; J Lingeman; F L Coe; E Worcester
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

6.  Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.

Authors:  John H Wiessner; Michael R Garrett; Richard J Roman; Neil S Mandel
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03

7.  Oxalate in renal stone disease: the terminal metabolite that just won't go away.

Authors:  Susan R Marengo; Andrea M P Romani
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-03
  7 in total
  3 in total

1.  Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.

Authors:  Benjamin K Canales; Joseph Ellen; Saeed R Khan; Marguerite Hatch
Journal:  J Urol       Date:  2013-03-14       Impact factor: 7.450

Review 2.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

3.  Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats.

Authors:  Ponnusamy Sasikumar; Sivasamy Gomathi; Kolandaswamy Anbazhagan; Albert Abhishek; Eldho Paul; Varadaraj Vasudevan; Sundaresan Sasikumar; Govindan Sadasivam Selvam
Journal:  J Biomed Sci       Date:  2014-08-30       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.